These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14486889)

  • 41. CHEMOTHERAPEUTIC PROPERTIES OF SOME NEW QUATERNARY AMMONIUM COMPOUNDS; THEIR CESTICIDAL ACTION AGAINST HYMENOLEPIS NANA.
    BHATTACHARYA BK; SEN AB
    Br J Pharmacol Chemother; 1965 Feb; 24(1):240-4. PubMed ID: 14302357
    [No Abstract]   [Full Text] [Related]  

  • 42. HOST RESISTANCE TO HYMENOLEPIS NANA. II. SPECIFICITY OF RESISTANCE TO REINFECTION IN THE DIRECT CYCLE.
    WEINMANN CJ
    Exp Parasitol; 1964 Dec; 15():514-26. PubMed ID: 14242264
    [No Abstract]   [Full Text] [Related]  

  • 43. [PERIPLANETA AMERICANA, NEW EXPERIMENTAL HOST OF HYMENOLEPIS NANA, FRATERNA VARIETY].
    CAVIER R; LEGER N
    C R Hebd Seances Acad Sci; 1965 Apr; 260():4078-9. PubMed ID: 14341954
    [No Abstract]   [Full Text] [Related]  

  • 44. Control of Hymenolepis nana infection as a measure to improve mouse colony welfare.
    Dovč A; Gregurić Gračner G; Tomažič I; Vlahović K; Pavlak M; Lindtner Knific R; Kralj K; Stvarnik M; Vergles Rataj A
    Acta Vet Hung; 2017 Jun; 65(2):208-220. PubMed ID: 28605969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effects of mepacrine on the different stages of the life cycle of Hymenolepis nana var. fraterna].
    Cavier R; Léger N
    Ann Pharm Fr; 1966; 24(9):623-32. PubMed ID: 5976349
    [No Abstract]   [Full Text] [Related]  

  • 46. [STUDY OF THE IMMUNITY OF RODENTS WITH RESPECT TO HYMENOLEPIS NANA. II. SPECIFIC AND ASPECIFIC FACTORS].
    BAILENGER J; ROGER G; PAUTRIZEL R
    Ann Parasitol Hum Comp; 1964; 39():33-52. PubMed ID: 14152065
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevalence of
    Yang D; Zhao W; Zhang Y; Liu A
    Korean J Parasitol; 2017 Jun; 55(3):351-355. PubMed ID: 28719963
    [No Abstract]   [Full Text] [Related]  

  • 48. Gene-based molecular characterization of
    Metwally DM; Al-Enezy HA; Al-Turaiki IM; El-Khadragy MF; Yehia HM; Al-Otaibi TT
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30670630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [EXPERIMENTAL STUDY OF THE EFFECTIVENESS OF THE COMBINATIONS OF AMINOACRICHINE, IOMEZAN AND MALE FERN EXTRACT. I. EFFECT OF THE IMAGINARY STAGE OF HYMENOLEPIS NANA IN WHITE MICE].
    KROTOV AI
    Med Parazitol (Mosk); 1964; 33():215-21. PubMed ID: 14198837
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of Hymenolepis nana infection with acranil.
    BERBERIAN DA
    Am J Trop Med Hyg; 1946 May; 26():339-43. PubMed ID: 20988060
    [No Abstract]   [Full Text] [Related]  

  • 51. Fatal
    Crouch EEV; Hollinger C; Zec S; McAloose D
    Vet Pathol; 2022 Jan; 59(1):169-172. PubMed ID: 34493121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and security of ivermectin given orally to rats naturally infected with Syphacia spp., Giardia spp. and Hymenolepis nana.
    Foletto VR; Vanz F; Gazarini L; Stern CA; Tonussi CR
    Lab Anim; 2015 Jul; 49(3):196-200. PubMed ID: 25480657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro hatching of oncospheres of Hymenolepis nana and Hymenolepis citelli (Cestoda: Cyclophyllidea).
    BERNTZEN AK; VOGE M
    J Parasitol; 1962 Feb; 48():110-9. PubMed ID: 13868297
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetic variability among Hymenolepis nana isolates from different geographical regions in China revealed by sequence analysis of three mitochondrial genes.
    Cheng T; Gao DZ; Zhu WN; Fang SF; Chen N; Zhu XQ; Liu GH; Lin RQ
    Mitochondrial DNA A DNA Mapp Seq Anal; 2016 Nov; 27(6):4646-4650. PubMed ID: 26642941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapeutic effects of 4-isothiocyanato-4'-nitrodiphenylamine (C9333-Go/CGP 4540) on infections with Nematospiroides dubius, Hymenolepis diminuta, Hymenolepis nana and Spirometra mansonoides.
    Middleton KR; Schaefer FW; Saz HJ
    Experientia; 1979 Feb; 35(2):243-4. PubMed ID: 421846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular characterization of
    Shahnazi M; Mehrizi MZ; Alizadeh SA; Heydarian P; Saraei M; Alipour M; Hajialilo E
    Afr Health Sci; 2019 Mar; 19(1):1346-1352. PubMed ID: 31148960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diarrhea from hymenolepis nana ].
    BASNUEVO JG
    Rev Kuba Med Trop Parasitol; 1957; 13(1-6):24-6. PubMed ID: 13466517
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunization of rodents against Hymenolepis infections using non-viable homologous oncospheres.
    Fan PC; Chung WC; Ito A
    Kaohsiung J Med Sci; 2004 Dec; 20(12):575-9. PubMed ID: 15696786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure to infect laboratory rodent hosts with human isolates of Rodentolepis (= Hymenolepis) nana.
    Macnish MG; Morgan UM; Behnke JM; Thompson RC
    J Helminthol; 2002 Mar; 76(1):37-43. PubMed ID: 12018194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heavy Hymenolepis nana infection possibly through organic foods: report of a case.
    Kim BJ; Song KS; Kong HH; Cha HJ; Ock M
    Korean J Parasitol; 2014 Feb; 52(1):85-7. PubMed ID: 24623888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.